CN113827640A - 一种治疗烧烫伤的外敷药 - Google Patents
一种治疗烧烫伤的外敷药 Download PDFInfo
- Publication number
- CN113827640A CN113827640A CN202111026613.9A CN202111026613A CN113827640A CN 113827640 A CN113827640 A CN 113827640A CN 202111026613 A CN202111026613 A CN 202111026613A CN 113827640 A CN113827640 A CN 113827640A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- scalds
- root
- treating burns
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010053615 Thermal burn Diseases 0.000 title claims abstract description 26
- 239000003814 drug Substances 0.000 title claims abstract description 25
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 19
- 239000000463 material Substances 0.000 claims abstract description 15
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 11
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 11
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 11
- 229940116229 borneol Drugs 0.000 claims abstract description 11
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 11
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims abstract description 11
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 11
- 239000010440 gypsum Substances 0.000 claims abstract description 11
- 239000008159 sesame oil Substances 0.000 claims abstract description 11
- 235000011803 sesame oil Nutrition 0.000 claims abstract description 11
- 238000010298 pulverizing process Methods 0.000 claims abstract description 8
- 238000007873 sieving Methods 0.000 claims abstract description 8
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims abstract description 8
- 235000001892 vitamin D2 Nutrition 0.000 claims abstract description 8
- 239000011653 vitamin D2 Substances 0.000 claims abstract description 8
- 244000173853 Sanguisorba officinalis Species 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 239000004570 mortar (masonry) Substances 0.000 claims abstract description 4
- 241000219061 Rheum Species 0.000 claims description 10
- 241001106477 Paeoniaceae Species 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 9
- 208000027418 Wounds and injury Diseases 0.000 abstract description 8
- 230000008961 swelling Effects 0.000 abstract description 8
- 206010052428 Wound Diseases 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 206010007247 Carbuncle Diseases 0.000 abstract description 6
- 230000029663 wound healing Effects 0.000 abstract description 6
- 238000001816 cooling Methods 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 238000005469 granulation Methods 0.000 abstract description 4
- 230000003179 granulation Effects 0.000 abstract description 4
- 208000015181 infectious disease Diseases 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 4
- 238000009825 accumulation Methods 0.000 abstract description 2
- 230000001580 bacterial effect Effects 0.000 abstract description 2
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 244000052769 pathogen Species 0.000 abstract description 2
- 230000001717 pathogenic effect Effects 0.000 abstract description 2
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 241000581682 Sanguisorba Species 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000012260 Accidental injury Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 208000024283 Gingival haemorrhages Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 208000025301 tympanitis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种治疗烧烫伤的外敷药,由以下重量份配比的药材制备而成,地榆炭40‑120份,寒水石25‑80份,赤芍10‑30份、大黄50‑150份,冰片0.1‑3份,香油5‑15份;其制备方法是:将大黄、地榆炭、寒水石、赤芍粉碎过120目筛,制成粉备用,将冰片在乳钵中研成粉末过200目筛备用,将大黄、地榆炭、寒水石、赤芍和冰片按重量组分混合、混匀,加入香油调成稀糊状。采用天然植物药材物理加工而成,外用在患处即可促进伤口痊愈,治疗效果稳定,方法简便,具有清热凉血生肌功效,能够抑制细菌的繁殖,有效防止烧烫伤创面的感染;具有清热解毒,消痈散结;活血止痛、消肿生肌,保证创面的快速修复性;具有疗效快,疗程短,成本低,痛苦少等优点。
Description
技术领域
本发明涉及医用药物技术领域,具体是指一种治疗烧烫伤的外敷药。
背景技术
烧烫伤是生活中常见的意外伤害,是由于热、化学物质、光、电以及放射线等所引起的组织损害,主要指皮肤或粘膜,严重者可伤及皮下组织,如肌肉、骨、关节甚至内脏,也是一种极其复杂的外伤性疾病。存在着创面疼痛、进行性坏死、易感染、瘢痕愈合等四大难题。
对于烧烫伤治疗,西医现采取先对创面进行清洗、消毒、清除坏死组织,用磺胺嘧银软膏涂抹创面,再用无菌纱布和棉垫包裹封闭创面,这个过程反复多次,疼痛始终伴随整个治疗过程,直到创面痊愈。每次治疗都使用清洗液、消毒液、棉花、纱布、抗生素,另外西药可能含有有激素,常伴有副作用,同时给患者带来药物和手术损伤。
中医认为烧烫伤后对于人体是一种毒火、湿热内攻,体表瘀滞、糜烂发生感染进一步对人体造成的伤害。因此,提出一种治疗烧烫伤的外敷药,用于烧烫伤的治疗。
发明内容
本发明要解决的技术问题是克服上述技术的缺陷,提供一种治疗烧烫伤的外敷药。
为解决上述技术问题,本发明提供的技术方案为一种治疗烧烫伤的外敷药,由以下重量份配比的药材制备而成:地榆炭40-120份,寒水石25-80份,赤芍10-30份、大黄50-150份,冰片0.1-3份,香油5-15 份;
作为改进,治疗烧烫伤的外敷药,由以下重量份配比的药材制备而成:地榆炭77-83份,寒水石48-53 份,赤芍15-22份,大黄96-103份,冰片0.5-1.5份,香油7-13份;
作为改进,治疗烧烫伤的外敷药,由以下重量份配比的药材制备而成:地榆炭80份,寒水石50份,赤芍18份,大黄100份,冰片0.5份,香油10份;
作为改进,其制备方法是:将大黄、地榆炭、寒水石、赤芍粉碎过120目筛,制成粉备用,将冰片在乳钵中研成粉末过200目筛备用,将大黄、地榆炭、寒水石、赤芍和冰片按重量组分混合、混匀,加入香油调成稀糊状。
所用的各中药材的药理药性如下:地榆炭:性味苦、酸、涩,微寒。归肝、大肠经。功能主治凉血止血,解毒敛疮。用于便血,痔血,血痢,崩漏,水火烫伤,痈肿疮毒。
寒水石:辛咸,寒入心、胃、肾经。清热降火,利窍,消肿。治时行热病,积热烦渴,吐泻,水肿,尿闭,齿衄,丹毒,烫伤。
冰片:味辛、苦,微寒;归心、肝、肺经。通诸窍,散郁火,去翳明目,消肿止痛。治口疮,中耳炎,痈肿,痔疮,目亦翳膜,蛲虫病。
大黄:味苦,寒。入胃、大肠、肝经。功能主治泻热通肠,凉血解毒,逐瘀通经。用于痈肿疔疮,瘀血经闭,跌打损伤,外治水火烫伤;用于火毒疮疡。
赤芍:味苦,性微寒。归肝经。清热凉血,散瘀止痛。用于热入营血,温毒发斑,吐血衄血,目赤肿痛,肝郁胁痛,经闭痛经,瘾瘕腹痛,跌扑损伤,痈肿疮疡。
香油:有清热解毒、凉血止痛之功效。
本发明与现有技术相比的优点在于:采用天然植物药材物理加工而成,外用在患处即可促进伤口痊愈,治疗效果稳定,方法简便,具有清热凉血生肌功效,能够抑制细菌的繁殖,有效防止烧烫伤创面的感染;具有清热解毒,消痈散结;活血止痛、消肿生肌,保证创面的快速修复性;避免交叉感染,加速伤口愈合,伤口愈合后表面光滑平坦,避免或减少疤痕的形成,具有疗效快,疗程短,成本低,痛苦少等优点。
具体实施方式
下面对本发明一种治疗烧烫伤的外敷药做进一步的详细说明。
一种治疗烧烫伤的外敷药,由以下重量份配比的药材制备而成:地榆炭40-120份,寒水石25-80份,赤芍10-30份、大黄50-150份,冰片0.1-3份,香油5-15份;
治疗烧烫伤的外敷药,由以下重量份配比的药材制备而成:地榆炭77-83份,寒水石48-53份,赤芍 15-22份,大黄96-103份,冰片0.5-1.5份,香油7-13份;
治疗烧烫伤的外敷药,由以下重量份配比的药材制备而成:由以下重量份配比的药材制备而成:地榆炭80份,寒水石50份,赤芍18份,大黄100份,冰片0.5份,香油10份;
治疗烧烫伤的外敷药,其制备方法:将大黄、地榆炭、寒水石、赤芍粉碎过120目筛,制成粉备用,将冰片在乳钵中研成粉末过200目筛备用,将大黄、地榆炭、寒水石、赤芍和冰片按重量组分混合、混匀,加入香油调成稀糊状。
以上对本发明及其实施方式进行了描述,这种描述没有限制性,所示的也只是本发明的实施方式之一,实际的结构并不局限于此。总而言之如果本领域的普通技术人员受其启示,在不脱离本发明创造宗旨的情况下,不经创造性的设计出与该技术方案相似的结构方式及实施例,均应属于本发明的保护范围。
Claims (4)
1.一种治疗烧烫伤的外敷药,其特征在于,由以下重量份配比的药材制备而成:地榆炭40-120份,寒水石25-80份,赤芍10-30份、大黄50-150份,冰片0.1-3份,香油5-15份。
2.根据权利要求1所述的一种治疗烧烫伤的外敷药,其特征在于,由以下重量份配比的药材制备而成:地榆炭77-83份,寒水石48-53份,赤芍15-22份,大黄96-103份,冰片0.5-1.5份,香油7-13份。
3.根据权利要求1所述的一种治疗烧烫伤的外敷药,其特征在于:由以下重量份配比的药材制备而成:地榆炭80份,寒水石50份,赤芍18份,大黄100份,冰片0.5份,香油10份。
4.根据权利要求1所述的一种治疗烧烫伤的外敷药,其特征在于,其制备方法:将大黄、地榆炭、寒水石、赤芍粉碎过120目筛,制成粉备用,将冰片在乳钵中研成粉末过200目筛备用,将大黄、地榆炭、寒水石、赤芍和冰片按重量组分混合、混匀,加入香油调成稀糊状。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111026613.9A CN113827640A (zh) | 2021-09-02 | 2021-09-02 | 一种治疗烧烫伤的外敷药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111026613.9A CN113827640A (zh) | 2021-09-02 | 2021-09-02 | 一种治疗烧烫伤的外敷药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113827640A true CN113827640A (zh) | 2021-12-24 |
Family
ID=78962013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111026613.9A Pending CN113827640A (zh) | 2021-09-02 | 2021-09-02 | 一种治疗烧烫伤的外敷药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113827640A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1679863A (zh) * | 2004-12-13 | 2005-10-12 | 孙合营 | 一种不留疤痕的烫伤药及其治疗方法 |
-
2021
- 2021-09-02 CN CN202111026613.9A patent/CN113827640A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1679863A (zh) * | 2004-12-13 | 2005-10-12 | 孙合营 | 一种不留疤痕的烫伤药及其治疗方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101310748B (zh) | 一种治疗烧烫伤的软膏 | |
CN102688383B (zh) | 一种用于治疗体表溃疡或溃烂的中药组合物 | |
CN102068576B (zh) | 痔疮膏 | |
CN106581439A (zh) | 一种治疗创伤、糖尿病足和皮肤溃烂的中药组合物及其制备方法 | |
CN104721406A (zh) | 一种治疗烧伤的中药组合物 | |
CN101254277B (zh) | 一种治疗烧烫伤的外敷膏剂 | |
CN104027483B (zh) | 治疗烧伤、烫伤的中药软膏及其制备方法 | |
CN113827640A (zh) | 一种治疗烧烫伤的外敷药 | |
CN101773654B (zh) | 治疗股骨头坏死的膏药及其生产工艺 | |
CN107596132A (zh) | 一种用于治疗烧伤、烫伤的药物组合物及其制备方法和应用 | |
CN107007761A (zh) | 一种中药烧伤油及其制备方法 | |
CN102028771A (zh) | 一种紫红疡油膏 | |
CN103599377A (zh) | 治疗烧伤的中药 | |
CN110624032A (zh) | 一种治疗烧烫伤的膏剂及其制备方法 | |
CN109045204A (zh) | 一种治疗烧伤和烫伤的中药液及其制备方法 | |
CN104352599A (zh) | 一种治疗烧烫伤的中药组合物 | |
CN107961322A (zh) | 一种治疗烧烫伤的中药组合物、中药制剂及其制备方法 | |
CN115887601B (zh) | 一种用于痔疮的组合物及其制备方法 | |
CN101810703A (zh) | 一种治疗烧烫伤的中药 | |
CN107050298A (zh) | 一种治疗烧烫伤皮损的中药膏配方及制备方法 | |
CN105832909A (zh) | 一种治疗皮肤坏死性溃疡的中药制剂 | |
CN105617273A (zh) | 一种用于促进伤口愈合的药物制剂及其用途 | |
CN115554377A (zh) | 一种治疗跌打损伤的膏药及其制备方法 | |
CN105477192A (zh) | 一种枯痔化管条及其制备方法 | |
CN103211956B (zh) | 治疗烧伤的外用药糊 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |